Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research

Objectives:. Since the beginning of the coronavirus disease 2019 pandemic, hundreds of thousands of patients have been treated in ICUs across the globe. The severe acute respiratory syndrome–associated coronavirus 2 virus enters cells via the angiotensin-converting enzyme 2 receptor and activates se...

Full description

Bibliographic Details
Main Authors: Philip A. Verhoef, MD, PhD, Sujatha Kannan, MD, Jamie L. Sturgill, PhD, Elizabeth W. Tucker, MD, Peter E. Morris, MD, Andrew C. Miller, MD, Travis R. Sexton, PhD, Jay L. Koyner, MD, Rana Hejal, MD, Scott C. Brakenridge, MD, Lyle L. Moldawer, PhD, Richard S. Hotchkiss, MD, Teresa M. Blood, BS, Monty B. Mazer, MD, Scott Bolesta, PharmD, Sheila A. Alexander, PhD, RN, Donna Lee Armaignac, PhD, Steven L. Shein, MD, Christopher Jones, MD, Caroline D. Hoemann, PhD, Allan Doctor, MD, Stuart H. Friess, MD, Robert I. Parker, MD, Alexandre T. Rotta, MD, Kenneth E. Remy, MD, MHSC, MSCI, for the Basic and Translational Science Committee of the Research Section for the Society of Critical Care Medicine
Format: Article
Language:English
Published: Wolters Kluwer 2021-03-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000374